Shortness of breath, chest pain, and palpitations occur as postacute sequelae of COVID-19,
but whether symptoms are associated with echocardiographic abnormalities, cardiac …

Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …

In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …

Immunothrombosis—immune-mediated activation of coagulation—is protective against
pathogens, but excessive immunothrombosis can result in pathological thrombosis and …

Background COVID-19 disease is accompanied by a dysregulated immune response and
hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate …

The capacity for social media to influence the utilization of re-purposed medicines to
manage COVID-19, despite limited availability of safety and efficacy data, is a cause for …

Background There is a paucity of data on outcomes for people with gout and COVID-19. We
aimed to assess whether gout is a risk factor for diagnosis of COVID-19 and COVID-19 …

Importance Hospitalized patients with COVID-19 pneumonia have high rates of morbidity
and mortality. Objective To assess the efficacy of colchicine in hospitalized patients with …

Monoclonal antibodies represent an exciting class of therapeutics against respiratory viral
infections. Notwithstanding their specificity and affinity, the conventional parenteral …

We report herein an alternative method for the synthesis of seleno-dibenzocycloheptenones
and seleno-spiro [5.5] trienones through the radical cyclization of biaryl ynones in the …